Quick Summary:
In an ever-evolving industry like biotechnology, pursuing innovation with confidence requires thorough understanding of the market landscape and precise insights. With the global In Vitro Protein Expression Systems market projected to reach an impressive $276.9 million by 2030, being equipped with substantial data and insights is critical to stay abreast of growing opportunities and upcoming trends.
Our comprehensive research report provides an in-depth analysis of this burgeoning market, detailing key segments and geographic markets that are forecast to experience substantial growth over the next eight years. To empower your strategic decision-making, the report features an analysis of select prominent competitors, coupled with data on global competitiveness and key competitor percentage market shares. Plus, you'll enjoy a year's worth of complimentary updates, guaranteeing timely access to the most recent developments. Explore the future of the In Vitro Protein Expression Systems market with our exhaustive report, enabling your business to seize the opportunities that lie ahead.
Global In Vitro Protein Expression Systems Market to Reach $276.9 Million by 2030
The global market for In Vitro Protein Expression Systems estimated at US$192.3 Million in the year 2022, is projected to reach a revised size of US$276.9 Million by 2030, growing at a CAGR of 4.7% over the analysis period 2022-2030. E-Coli, one of the segments analyzed in the report, is projected to record 5.1% CAGR and reach US$147.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Mammalian segment is readjusted to a revised 4.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $56.3 Million, While China is Forecast to Grow at 4.3% CAGR
The In Vitro Protein Expression Systems market in the U.S. is estimated at US$56.3 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$48.6 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 3.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.Select Competitors (Total 12 Featured) -
- Bioneer Corporation
- biotechrabbit GmbH
- CellFree Sciences Co., Ltd.
- Cube Biotech GmbH
- GeneCopoeia, Inc.
- Jena Bioscience GmbH
- New England Biolabs, Inc.
- Promega Corporation
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Frequently Asked Questions about the Global Market for In Vitro Protein Expression Systems
What is the estimated value of the Global Market for In Vitro Protein Expression Systems?
The Global Market for In Vitro Protein Expression Systems was estimated to be valued at $192.3 Million in 2022.
What is the growth rate of the Global Market for In Vitro Protein Expression Systems?
The growth rate of the Global Market for In Vitro Protein Expression Systems is 4.7%, with an estimated value of $276.9 Million by 2030.
What is the forecasted size of the Global Market for In Vitro Protein Expression Systems?
The Global Market for In Vitro Protein Expression Systems is estimated to be worth $276.9 Million by 2030.
Who are the key companies in the Global Market for In Vitro Protein Expression Systems?
Key companies in the Global Market for In Vitro Protein Expression Systems include Bioneer Corporation, biotechrabbit GmbH, CellFree Sciences Co., Ltd., Cube Biotech GmbH, GeneCopoeia, Inc., Jena Bioscience GmbH, New England Biolabs, Inc., Promega Corporation, Takara Bio, Inc. and Thermo Fisher Scientific, Inc..
| Report Attribute | Details |
|---|---|
| No. of Pages | 179 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 192.3 Million |
| Forecasted Market Value ( USD | $ 276.9 Million |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- In Vitro Protein Expression Systems - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 3: World 16-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 4: World In Vitro Protein Expression Systems Market Analysis of Annual Sales in US$ for Years 2014 through 2030
- Table 5: World Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- Table 6: World Historic Review for In Vitro Protein Expression Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 7: World 16-Year Perspective for In Vitro Protein Expression Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
- Table 8: World Recent Past, Current & Future Analysis for E-Coli by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- Table 9: World Historic Review for E-Coli by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 10: World 16-Year Perspective for E-Coli by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 11: World Recent Past, Current & Future Analysis for Mammalian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- Table 12: World Historic Review for Mammalian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 13: World 16-Year Perspective for Mammalian by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 14: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- Table 15: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 16: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 17: World Recent Past, Current & Future Analysis for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- Table 18: World Historic Review for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 19: World 16-Year Perspective for Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 20: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- Table 21: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 22: World 16-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 23: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- Table 24: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 25: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
UNITED STATES
- In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 26: USA Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 27: USA Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 28: USA 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2023 & 2030
- Table 29: USA Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 30: USA Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 31: USA 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2023 & 2030
CANADA
- Table 32: Canada Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 33: Canada Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 34: Canada 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2023 & 2030
- Table 35: Canada Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 36: Canada Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 37: Canada 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2023 & 2030
JAPAN
- In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 38: Japan Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 39: Japan Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 40: Japan 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2023 & 2030
- Table 41: Japan Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 42: Japan Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 43: Japan 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2023 & 2030
CHINA
- In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 44: China Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 45: China Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 46: China 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2023 & 2030
- Table 47: China Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 48: China Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 49: China 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2023 & 2030
EUROPE
- In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 50: Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 51: Europe Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 52: Europe 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2023 & 2030
- Table 53: Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- Table 54: Europe Historic Review for In Vitro Protein Expression Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 55: Europe 16-Year Perspective for In Vitro Protein Expression Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
- Table 56: Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 57: Europe Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 58: Europe 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2023 & 2030
FRANCE
- In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 59: France Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 60: France Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 61: France 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2023 & 2030
- Table 62: France Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 63: France Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 64: France 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2023 & 2030
GERMANY
- In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 65: Germany Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 66: Germany Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 67: Germany 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2023 & 2030
- Table 68: Germany Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 69: Germany Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 70: Germany 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2023 & 2030
ITALY
- Table 71: Italy Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 72: Italy Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 73: Italy 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2023 & 2030
- Table 74: Italy Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 75: Italy Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 76: Italy 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2023 & 2030
UNITED KINGDOM
- In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 77: UK Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 78: UK Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 79: UK 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2023 & 2030
- Table 80: UK Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 81: UK Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 82: UK 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2023 & 2030
REST OF EUROPE
- Table 83: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 84: Rest of Europe Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 85: Rest of Europe 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2023 & 2030
- Table 86: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 87: Rest of Europe Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 88: Rest of Europe 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2023 & 2030
ASIA-PACIFIC
- In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 89: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 90: Asia-Pacific Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 91: Asia-Pacific 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2023 & 2030
- Table 92: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 93: Asia-Pacific Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 94: Asia-Pacific 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2023 & 2030
REST OF WORLD
- Table 95: Rest of World Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 96: Rest of World Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 97: Rest of World 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2023 & 2030
- Table 98: Rest of World Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- Table 99: Rest of World Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- Table 100: Rest of World 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2023 & 2030
Companies Mentioned
A selection of companies mentioned in this report includes:
- Bioneer Corporation
- biotechrabbit GmbH
- CellFree Sciences Co., Ltd.
- Cube Biotech GmbH
- GeneCopoeia, Inc.
- Jena Bioscience GmbH
- New England Biolabs, Inc.
- Promega Corporation
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
